在未破裂的脊髓底剖析动脉瘤中,他类药物减少了血管壁MRI的壁增强:一项随机对照试验

Yisen Zhang1,2, Chao Wang1,2, Linggen Dong1,2

  • 1Department of Neurosurgery and Department of Interventional Neuroradiology, Beijing Tiantan Hospital and Beijing Neurosurgical Institute, Capital Medical University, NansihuanXilu 119, Fengtai District, Beijing, China 100070.

Radiology
|December 23, 2025
PubMed
概括

正如血管壁MRI所示,阿托瓦斯塔丁显著降低了脊髓基底剖析动脉瘤 (VBDA) 的炎症. 这项研究表明,他类药物可能是减少VBDA炎症和中风风险的潜在治疗方法.